These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31949797)

  • 1. Improved radioiodine-131 imaging of prostatic carcinoma using the sodium iodide symporter gene under control of the survivin promoter.
    Zhao Z; Huang R; Cai H; Liu B; Zeng Y; Kuang A
    Int J Clin Exp Pathol; 2018; 11(8):4067-4072. PubMed ID: 31949797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting of tumor radioiodine therapy by expression of the sodium iodide symporter under control of the survivin promoter.
    Huang R; Zhao Z; Ma X; Li S; Gong R; Kuang A
    Cancer Gene Ther; 2011 Feb; 18(2):144-52. PubMed ID: 21037556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radionuclide imaging and therapy in malignant melanoma after survivin promoter-directed sodium iodide symporter gene transfer in vitro and in vivo.
    Zhao Z; Huang R; Cai H; Liu B; Zeng Y; Kuang A
    Int J Clin Exp Pathol; 2019; 12(2):613-618. PubMed ID: 31933867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting of pertechnetate imaging of HepG2 hepatocellular carcinoma through the transduction of the survivin promoter controls the sodium iodide symporter.
    Zhao Z; Huang R; Cai H; Liu B; Zeng Y; Kuang A
    Int J Clin Exp Pathol; 2017; 10(11):11037-11043. PubMed ID: 31966449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probasin promoter (ARR(2)PB)-driven, prostate-specific expression of the human sodium iodide symporter (h-NIS) for targeted radioiodine therapy of prostate cancer.
    Kakinuma H; Bergert ER; Spitzweg C; Cheville JC; Lieber MM; Morris JC
    Cancer Res; 2003 Nov; 63(22):7840-4. PubMed ID: 14633711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A probasin promoter, conditionally replicating adenovirus that expresses the sodium iodide symporter (NIS) for radiovirotherapy of prostate cancer.
    Trujillo MA; Oneal MJ; McDonough S; Qin R; Morris JC
    Gene Ther; 2010 Nov; 17(11):1325-32. PubMed ID: 20428214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter.
    Spitzweg C; O'Connor MK; Bergert ER; Tindall DJ; Young CY; Morris JC
    Cancer Res; 2000 Nov; 60(22):6526-30. PubMed ID: 11103823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-targeted radionuclide imaging and therapy based on human sodium iodide symporter gene driven by a modified telomerase reverse transcriptase promoter.
    Kim SH; Chung HK; Kang JH; Kim KI; Jeon YH; Jin YN; Yun CO; Chung JK
    Hum Gene Ther; 2008 Sep; 19(9):951-7. PubMed ID: 18810799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glial fibrillary acidic protein promoters direct adenovirus early 1A gene and human telomerase reverse transcriptase promoters direct sodium iodide symporter expression for malignant glioma radioiodine therapy.
    Li W; Tan J; Wang P; Li N; Li C
    Mol Cell Biochem; 2015 Jan; 399(1-2):279-89. PubMed ID: 25410753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Radioiodide treatment mediated by adenovirus transfer of human sodium iodide symporter gene into androgen-independent prostate cancer].
    Huang R; Ma X; Li S; Mu D; Gong R; Kuang A
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Oct; 27(5):1080-4. PubMed ID: 21089675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoic acid-induced stimulation of sodium iodide symporter expression and cytotoxicity of radioiodine in prostate cancer cells.
    Spitzweg C; Scholz IV; Bergert ER; Tindall DJ; Young CY; Göke B; Morris JC
    Endocrinology; 2003 Aug; 144(8):3423-32. PubMed ID: 12865321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines.
    Spitzweg C; Zhang S; Bergert ER; Castro MR; McIver B; Heufelder AE; Tindall DJ; Young CY; Morris JC
    Cancer Res; 1999 May; 59(9):2136-41. PubMed ID: 10232600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioiodine therapy of colon cancer following tissue-specific sodium iodide symporter gene transfer.
    Scholz IV; Cengic N; Baker CH; Harrington KJ; Maletz K; Bergert ER; Vile R; Göke B; Morris JC; Spitzweg C
    Gene Ther; 2005 Feb; 12(3):272-80. PubMed ID: 15510175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional Radionuclide Imaging, In-Vitro Radioiodine Uptake Estimation and RT-PCR in the Evaluation of Sodium Iodide Symporter (NIS) Expression and Functionality in Breast Cancer: A Pilot Study.
    Joseph JK; Patel RB; Damle AA; Nair N; Badwe RA; Basu S
    Indian J Surg Oncol; 2013 Mar; 4(1):80-91. PubMed ID: 24426705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reintroducing the Sodium-Iodide Symporter to Anaplastic Thyroid Carcinoma.
    Schmohl KA; Dolp P; Schug C; Knoop K; Klutz K; Schwenk N; Bartenstein P; Nelson PJ; Ogris M; Wagner E; Spitzweg C
    Thyroid; 2017 Dec; 27(12):1534-1543. PubMed ID: 29032724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective control of tumor growth through spatial and temporal control of theranostic sodium iodide symporter (
    Tutter M; Schug C; Schmohl KA; Urnauer S; Schwenk N; Petrini M; Lokerse WJM; Zach C; Ziegler S; Bartenstein P; Weber WA; Wagner E; Lindner LH; Nelson PJ; Spitzweg C
    Theranostics; 2020; 10(10):4490-4506. PubMed ID: 32292510
    [No Abstract]   [Full Text] [Related]  

  • 17. In vivo molecular imaging and radionuclide (131I) therapy of human nasopharyngeal carcinoma cells transfected with a lentivirus expressing sodium iodide symporter.
    Shi S; Zhang M; Guo R; Miao Y; Hu J; Xi Y; Li B
    PLoS One; 2015; 10(1):e0116531. PubMed ID: 25621996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioiodine therapy for castration-resistant prostate cancer following prostate-specific membrane antigen promoter-mediated transfer of the human sodium iodide symporter.
    Gao XF; Zhou T; Chen GH; Xu CL; Ding YL; Sun YH
    Asian J Androl; 2014; 16(1):120-3. PubMed ID: 24369144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone enhances the cytotoxic effect of radioiodine therapy in prostate cancer cells expressing the sodium iodide symporter.
    Scholz IV; Cengic N; Göke B; Morris JC; Spitzweg C
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1108-16. PubMed ID: 15001595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term radioiodine retention and regression of liver cancer after sodium iodide symporter gene transfer in wistar rats.
    Faivre J; Clerc J; Gérolami R; Hervé J; Longuet M; Liu B; Roux J; Moal F; Perricaudet M; Bréchot C
    Cancer Res; 2004 Nov; 64(21):8045-51. PubMed ID: 15520214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.